Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs by CNBC Markets | September 23, 2025 11:08 pm | US Markets More production capacity for the obesity pill is crucial as Eli Lilly races to bring it to market and tries to maintain its dominance in the GLP-1 market.
